What are the common medications used to treat ringworm (tinea infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ringworm (Tinea) Medications

For localized tinea corporis or tinea cruris, start with topical terbinafine or naftifine applied once or twice daily for 1-2 weeks, as these are the most effective topical agents with the shortest treatment duration.

Topical Therapy for Localized Skin Infections

First-Line Topical Agents

  • Terbinafine 1% cream is highly effective for tinea corporis and tinea cruris, requiring only 1-2 weeks of treatment with once or twice daily application 1, 2.

  • Naftifine 1% cream demonstrates superior efficacy compared to placebo (mycological cure RR 2.38, clinical cure RR 2.42) and requires shorter treatment duration than azoles 3.

  • Azole antifungals (clotrimazole, miconazole, ketoconazole) are effective alternatives applied twice daily for 2-4 weeks, though they require longer treatment duration than allylamines 2, 3.

Treatment Duration by Site

  • Tinea corporis and tinea cruris: Treat for 2 weeks with azoles or 1-2 weeks with allylamines, continuing at least 1 week after clinical clearing 2.

  • Tinea pedis: Treat for 4 weeks with azoles or 1-2 weeks with allylamines 2, 4.

Important Caveat About Combination Products

  • Avoid antifungal-corticosteroid combinations as routine therapy, as they may cause skin atrophy and promote resistance 1. These should only be considered when significant inflammation is present, and only for short-term use 2.

Oral Therapy Indications

When to Use Systemic Treatment

Oral antifungals are required for:

  • Tinea capitis (scalp ringworm) - topical therapy alone is ineffective as the infection involves hair follicles 1, 5.

  • Onychomycosis (nail infections) - topical agents cannot adequately penetrate the nail 6, 7.

  • Extensive disease covering large body surface areas where topical application is impractical 1, 5.

  • Failed topical therapy after appropriate duration of treatment 1.

  • Immunocompromised patients who may not respond adequately to topical treatment 1.

  • Hyperkeratotic tinea pedis unresponsive to topical monotherapy 5.

First-Line Oral Agents

  • Terbinafine 250 mg daily is first-line for tinea capitis and onychomycosis due to excellent efficacy, tolerability, and low cost 1.

    • For tinea capitis: 250 mg daily for 4-6 weeks 1
    • For onychomycosis: 250 mg daily for fingernails (at least 4 months) or toenails (at least 6 months) 6, 7
  • Griseofulvin is an alternative for tinea capitis when terbinafine cannot be used 6.

    • Adult dose: 500 mg daily (can start at 750 mg-1 g daily for extensive disease, then reduce to 500 mg) 6
    • Pediatric dose (>2 years): 10 mg/kg daily 6
    • Duration: Tinea capitis 4-6 weeks, tinea corporis 2-4 weeks, tinea pedis 4-8 weeks 6

Alternative Oral Agents

  • Fluconazole: 50-100 mg daily or 150 mg weekly for 2-3 weeks for tinea corporis/cruris; 150 mg weekly for tinea pedis 4.

  • Itraconazole: 100 mg daily for 2 weeks or 200 mg daily for 7 days for tinea corporis/cruris; 100 mg daily for 2 weeks or 400 mg daily for 1 week for tinea pedis 4.

Critical Diagnostic Requirement

Always confirm diagnosis with laboratory testing (KOH preparation, fungal culture, or nail biopsy) before initiating systemic therapy 6, 7, 1. Clinical diagnosis alone is unreliable as many conditions mimic tinea infections (eczema, psoriasis, dystrophic nails from trauma) 1.

Common Pitfalls to Avoid

  • Do not use griseofulvin or terbinafine for Candida infections - these agents are only effective against dermatophytes, not yeasts 6.

  • Do not stop treatment when lesions clear clinically - continue for at least 1 week after clinical resolution to prevent relapse 2.

  • Do not use topical therapy alone for tinea capitis - this will fail and may worsen inflammation 5.

  • Address hygiene and moisture control concurrently with antifungal therapy to prevent reinfection 6, 2.

Emerging Resistant Infections

  • Some emerging tinea infections may not respond to first-line topical or oral antifungals and may require prolonged oral therapy with specialized diagnostic testing 1.

  • Antifungal stewardship, particularly avoiding combination antifungal-corticosteroid products, is essential to prevent resistance 1.

References

Research

Diagnosis and Management of Tinea Infections.

American family physician, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.